Signal transducer and activator of transcription 5A (STAT5A) (STAT5A)

Signal transducer and activator of transcription 5A (STAT5A) is a member of the STAT family of transcription factors that mediates cellular responses to a wide array of cytokines and growth factors, including prolactin, growth hormone, and interleukins (UniProt P42229). The Src homology 2 (SH2) domain is a critical structural component of STAT5A, serving as the docking site for phosphorylated tyrosine residues on upstream kinases and facilitating the essential dimerization step required for nuclear translocation and DNA binding (PubMed: 29070659). In many hematologic and solid malignancies, STAT5A is constitutively activated, driving the expression of genes that promote cell cycle progression and inhibit apoptosis (PubMed: 30635433). Therapeutic strategies targeting the STAT5A SH2 domain aim to disrupt these protein-protein interactions, effectively silencing the oncogenic signaling pathway (PubMed: 25607126). While several small-molecule inhibitors like AC-4-130 and IST5-002 have shown preclinical efficacy, achieving high selectivity over the closely related STAT5B isoform remains a significant challenge in drug development (PubMed: 29453241).

Other names

STAT5Mammary gland factorMGFSTAT5A SH2 domain

Inhibition of the SH2 domain to prevent protein dimerization, nuclear translocation, and subsequent DNA binding/transcriptional activation.